GI Cancer

Read the most current news and learn about the latest research developments in gastrointestinal (GI) cancer. Cancer Nursing Today provides the latest clinical findings and perspectives on GI cancers, including liver cancer immunotherapy, risk-prediction models, the link between diet and colorectal cancer, and more. From radiotherapy and chemotherapy to the role of screening in early detection, learn how GI cancer care and research are moving forward.

FDA Approves Zolbetuximab Plus Chemotherapy for Certain Patients With Advanced Gastric, GEJ Cancer
The US Food and Drug Administration (FDA) approved zolbetuximab-clzb (Vyloy, Astellas Pharma US, Inc.) plus fluoropyrimidine- and platinum-containing chemotherapy as a first-line treatment for adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors are CLDN18.2 positive, as determined by an FDA-approved test. ...
Advertisement
Advertisement

Knowledge Hubs

Best Practices
Best Practices

Trending

Advertisement
Advertisement
Latest News